CONTACT LENS DRUG DELIVERY DEVICE
First Claim
Patent Images
1. A drug-eluting contact lens comprising:
- a drug release material comprising at least one drug, wherein the contact lens provides substantially zero-order release of the at least one drug over a period beginning no later than about 120 hours from first exposure of the lens to the eye or physiologically-suitable saline solution.
3 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates generally to devices and methods for administering one or more active agents to the eye of a human or animal patient in need thereof, and more particularly to devices for application to the cornea which release active agent to the eye in a controlled manner.
-
Citations
101 Claims
-
1. A drug-eluting contact lens comprising:
a drug release material comprising at least one drug, wherein the contact lens provides substantially zero-order release of the at least one drug over a period beginning no later than about 120 hours from first exposure of the lens to the eye or physiologically-suitable saline solution. - View Dependent Claims (2, 3, 4, 7, 9, 11, 12, 17, 19, 20, 22, 26, 30, 93, 94, 95, 96, 97, 98, 99, 100, 101)
-
5-6. -6. (canceled)
-
8. (canceled)
-
10. (canceled)
-
13-16. -16. (canceled)
-
18. (canceled)
-
21. (canceled)
-
23-25. -25. (canceled)
-
27-29. -29. (canceled)
-
31. A drug-eluting contact lens comprising:
-
an optical pathway wherein the line of vision of a wearer of the contact lens passes through the pathway; and a substantially continuous drug carrying zone comprising at least one drug for release by the contact lens proximate the eye, the zone surrounding the optical pathway but not residing in the optical pathway, wherein the drug carrying zone is encapsulated by a lens material. - View Dependent Claims (32, 33)
-
-
34-37. -37. (canceled)
-
38. A drug-eluting contact lens comprising:
a drug release material comprising at least one drug, and constructed and arranged to release the drug from the contact lens proximate the eye at a rate of at least 1 microgram per hour, for a period of time of at least 120 hours. - View Dependent Claims (39, 40)
-
41-92. -92. (canceled)
Specification